To be awarded to an individual with an outstanding contribution to the field of haemoglobinopathies.
The University of Nicosia (UNIC) Medical School and the Thalassaemia International Federation (TIF) jointly award, on a biennial basis, the ‘Panos Englezos Prize’, to an individual who has made an outstanding contribution in one or more of the following:
- the areas of public health relevant to haemoglobin disorders
- the improvement of medical and other care of patients with haemoglobin disorders
- the improvement of the quality of life of patients with haemoglobin disorders or other chronic/ genetic diseases
- a scientific/medical advancement for the prevention and/or management of any other disease that could be applied to make a difference in the prevention and/or management or holistic care or cure of haemoglobin disorders.
Application Process
Opening date: 1st March 2024
Closing date: 30th April 2024
Selection Committee: The Selection Committee comprises five members of the UNIC Medical School faculty
Receipt of Award: 27 June 2024 during the UNIC Medical School Graduation Ceremony
Nomination Process |
Nominations are invited by:
- An individual (or a group) with medical/scientific/academic capacity and with an international reputation in the field in which they propose the nominee for the prize.
- A Patient Organisation* (one or more jointly) if the nomination concerns a social contribution. If the nomination concerns an academic or a scientific achievement in collaboration with an academic department with an international reputation in the field of haemoglobin
* The Patient Organisation needs to be officially registered in the country in which it operates and an official member of TIF (General or Voting) for more than a year.
Nominations should be submitted with all supporting documents (Completed Nomination Form, Nomination Letter of Support and the Nominee CV) and sent electronically to [email protected] with a copy to [email protected].
A Few Words about the Prize:
The ‘Panos Englezos Prize’ was initiated in 2016 through a decision of the Board of Directors of TIF in honour and recognition of the vast, lifelong and voluntary contribution of Mr Panos Englezos, TIF President and parent of a thalassaemic son. The promotion and securement of the rights of patients with thalassaemia globally for equal access to quality health and other care, has been his lifetime commitment – a commitment across religious, cultural, social, gender and language barriers.